The daily business briefing: December 15, 2021

Pfizer says its COVID pill helps prevent severe illness, producer prices to suppliers jump by a record 9.6 percent, and more

Pfizer
Pfizer
(Image credit: JOHN THYS/AFP via Getty Images)

1. Pfizer says its COVID pill effective in preventing severe illness

Pfizer said Tuesday that a study had confirmed that its coronavirus pill helps prevent severe COVID-19. The drugmaker also said the antiviral pill proved effective in laboratory studies against the new Omicron variant, which is expected to overtake the Delta variant as the dominant strain in the United States within weeks. "We are confident that, if authorized or approved, this potential treatment could be a critical tool to help quell the pandemic," Pfizer CEO Albert Bourla said in a statement. Pfizer last month submitted preliminary data to the Food and Drug Administration, requesting authorization to distribute the pill, known as Paxlovid. The new results are expected to increase the likelihood that the pill will win approval.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
Harold Maass, The Week US

Harold Maass is a contributing editor at The Week. He has been writing for The Week since the 2001 debut of the U.S. print edition and served as editor of TheWeek.com when it launched in 2008. Harold started his career as a newspaper reporter in South Florida and Haiti. He has previously worked for a variety of news outlets, including The Miami Herald, ABC News and Fox News, and for several years wrote a daily roundup of financial news for The Week and Yahoo Finance.